AINDEX
Markets

IRADIMED CORPORATION (IRMD)

IRMDNASDAQ-GMMedical/Dental Instruments

$86.05

-0.8900 (-1.02%) today

Regular session, Nov 10, 1:33 PM ET

-1.02% 1D
Market cap
$1.10bn
P/E
46.0
EPS, last 4 quarters
$1.87
Dividend yield
0.92%
Day range
$84.58 to $87.00
52-week range
$76.35 to $107.90
Average volume
127.9k
Previous close
$86.94

Earnings

next estimate $0.5500

Next report

Dec 2025

+13.6%

Mar 2026

+9.8%

Jun 2026

-2.4%

Sep 2026

-1.9%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$22.69m$21.98m$20.46m$24.20m
Gross profit$17.03m$16.81m$15.16m$18.46m
Operating income$7.09m$7.24m$6.39m$8.14m
Net income$6.44m$5.82m$5.22m$6.51m

Last four quarters: revenue $89.34m, margin 26.9%, free cash flow $26.14m

News

8 latest

The company

IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ('MRI') compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only known provider of a non-magnetic intravenous ('IV') infusion pump system specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-GM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.